[SCHEDULE 13D/A] Flora Growth Corp. SEC Filing

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

SCHEDULE 13D/A

Rhea-AI Filing Summary

PermRock Royalty Trust (NYSE: PRT) filed an 8-K (Item 2.02) dated 21 Jul 2025 to disclose its next monthly cash distribution. Unitholders of record on 31 Jul 2025 will receive a total of US$395,288.31, equal to US$0.032491 per trust unit, on 14 Aug 2025. The payout is based on net revenue generated from May 2025 oil-and-gas production.

The disclosure is furnished (not filed) under the Exchange Act, limiting potential liability under Section 18. Aside from attaching the press release (Ex. 99.1), the Trust reported no additional operational or financial developments. Argent Trust Company continues to serve as trustee; the Trust has no directors or executive officers.

Insights

TL;DR: Routine monthly payout; maintains income profile but lacks new catalysts or production detail鈥攏eutral for valuation.

The declared US$0.032491 per-unit distribution implies an annualized yield near prior levels and is consistent with PRT鈥檚 pass-through model. Because the filing omits production volumes, realized prices or comparison to prior months, investors cannot assess momentum in underlying cash flow. Commodity price swings, not this notice, will likely drive unit price. Impact is therefore neutral.

TL;DR: Payment date clarity aids cash-flow planning; size alone insufficient to move the needle鈥攏eutral impact.

The trust continues predictable monthly distributions鈥攊mportant for income mandates. However, at roughly US$0.03 per unit, the payout is neither a step-change nor an unexpected reduction, so it should not materially affect discount-rate assumptions or portfolio weightings. Without guidance on future distributions, I rate the event neutral.

07/21/2025 - 12:59 PM

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 2)

Flora Growth Corp.

(Name of Issuer)

Common Shares, no par value

(Title of Class of Securities)

339764102

(CUSIP Number)

Dany Vaiman
3230 W. Commercial Blvd., Suite 180,
Fort Lauderdale, FL, 33309
(416) 861-2267

Richard Raymer
66 Wellington Street W., Suite 3400,
Toronto, A6, M5K 1E6
(416) 367-7370

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

05/09/2025

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of 搂搂 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13D

CUSIP No.

339764102

Name of reporting person

Vaiman Dany

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Citizenship or place of organization

CANADA (FEDERAL LEVEL)

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 1,078,011.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 1,078,011.00
10	Shared Dispositive Power 0.00

Aggregate amount beneficially owned by each reporting person

1,078,011.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Percent of class represented by amount in Row (11)

4.8 %

Type of Reporting Person (See Instructions)

SCHEDULE 13D

Item 1.

Security and Issuer

(a)

Title of Class of Securities:

Common Shares, no par value

(b)

Name of Issuer:

Flora Growth Corp.

(c)

Address of Issuer's Principal Executive Offices:

3230 W. Commercial Blvd., Suite 180, Fort Lauderdale, FLORIDA , 33309.

Item 2.

Identity and Background

(a)

Dany Vaiman

(b)

3230 W. Commercial Blvd, Suite 180 Fort Lauderdale, FL 33309

(c)

Chief Financial Officer of Issuer

(d)

N/A - None

(e)

N/A - None

(f)

Canada

Item 3.

Source and Amount of Funds or Other Consideration

Item 4.

Purpose of Transaction

Increase in Issuer's outstanding shares

Item 5.

Interest in Securities of the Issuer

(a)

4.8%

(b)

1,078,011

(c)

Increase to Issuer's outstanding shares

(d)

N/A

(e)

N/A

Item 6.

Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer

N/A

Item 7.

Material to be Filed as Exhibits.

N/A

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Vaiman Dany

Signature:	/s/ Dany Vaiman
Name/Title:	Vaiman Dany
Date:	07/21/2025

Source:

AG真人官方